Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 

Hepatitis C Virus and HIV Co-Infection-2016 Update


Date: Jan 21, 2017 11:00 AM - 12:00 PM

Location: Howard University Hospital-Towers Building

CE Hours

1.00

CE Units

0.100

Registration closes on Feb 03, 2017 10:50 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacist

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Requirements for CE Credit

CPE Monitor: Requirement to Track your CPE
Important new requirement from the Accreditation Council for Pharmacy Education and the National Association of Boards of Pharmacy for all pharmacists and technicians who obtain CPE credit. The CPE Monitor system will securely track all your completed CPE credits in a central system.

https://store.nabp.net/OA_HTML/xxnabpibeGblLogin.jsp 

 

 

Registration closes on Feb 03, 2017 at 10:50 PM

Registration Closed  

Objectives

  • Explain the impact of HIV on the progression of Hepatitis C co-infection.
  • Improve awareness and understanding of emerging therapies for chronic Hepatitis C genotype 1 infection.
  • Identify potential therapeutic-related challenges and clinical considerations associated with treatment of Hepatitis C in the HIV/HCV co-infected patient.
  • Formulate an appropriate management strategy for drugs interactions associated with treatment of HIV and HCV.

Speaker(s)/Author(s)

Mia Barnes, PharmD, BCPS, PharmD
Clinical Pharmacist, George Washington University

Activity Number

0010-0000-16-007-L01-P
Date: 01/21/17
Time: 11:00 AM - 12:00 PM

CE Hours

1.00

Location

Howard University College of Pharmacy
Registration Closed